UK panel recommends Covid-19 booster jabs for over-50s, healthcare workers

Britain's expert advisory panel recommended that a third booster dose of a COVID-19 vaccine would be beneficial for people aged over 50 and frontline healthcare workers

UK booster dose
Photo: Bloomberg
Press Trust of India London
2 min read Last Updated : Sep 14 2021 | 5:53 PM IST

Britain's expert advisory panel on Tuesday recommended that a third booster dose of a COVID-19 vaccine would be beneficial for people aged over 50 and frontline healthcare workers to boost their protection against the deadly virus over the winter months.

The Joint Committee on Vaccination and Immunisation's (JCVI) recommendation notes that six months after a second COVID vaccine dose is the optimum timing to boost immunity with another dose, with the Pfizer/BioNTech or Moderna vaccines among those ideal for use as a third jab.

"Getting a dose too early may mean they do not need it as they still have a high level of protection, and as we've seen with the gap between the first and second dose, you don't want to have it too early," JCVI Chair Professor Wei Shen Lim told reporters at a briefing on Tuesday.

He also indicated a recurrent booster every six months may not be needed but it is too early to be sure about that.

England's Deputy Chief Medical Officer Professor Jonathan Van-Tam said following the JCVI decision, he expects the boosters to be offered "within days" and they will be taking place at mass vaccination centres and GPs.

Van-Tam warned of a "bumpy" winter ahead despite the vaccines having been "incredibly successful" and had so far prevented an estimated 24 million COVID-19 cases and 112,000 deaths.

"But we also know that this pandemic is still active. We are not past the pandemic, we are in an active phase still," he said.

"We know that this winter could quite possibly be bumpy at times and we know that other respiratory viruses such as flu and RSV are highly likely to make their returns," he added.

The JCVI briefing comes ahead of a government statement laying out its winter strategy for tackling COVID-19 without having to resort to further lockdowns.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccinehealthcareUK govt

First Published: Sep 14 2021 | 5:53 PM IST

Next Story